The hepatitis C virus replicon system: From basic research to clinical application

Journal of Hepatology

Volumn 43, Issue 2, 2005, Pages 210-216

  Bartenschlager, Ralf ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CILUPREVIR; PROTEINASE INHIBITOR; RIBAVIRIN; VIRUS PROTEIN; VIRUS RNA;

ANTIBIOTIC RESISTANCE; ANTIVIRAL ACTIVITY; BIOTECHNOLOGY; CELL CULTURE; DRUG DESIGN; DRUG EFFECT; DRUG MECHANISM; GENOTYPE; HEPATITIS C VIRUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPLICON; REVIEW; RNA REPLICATION; VIRION; VIRUS GENOME; VIRUS INHIBITION; VIRUS MUTATION; VIRUS PARTICLE; VIRUS REPLICATION;

EID: 21844453965     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.05.013     Document Type: Article

References (54)

1. Q.L. Choo, G. Kuo, A.J. Weiner, L.R. Overby, D.W. Bradley, and M. Houghton Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome Science 244 1989 359 362
2. G. Kuo, Q.L. Choo, H.J. Alter, G.L. Gitnick, A.G. Redeker, and R.H. Purcell An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis Science 244 1989 362 364
3. T. Pietschmann, and R. Bartenschlager Tissue culture and animal models for hepatitis C virus Clin Liver Dis 7 2003 23 43
4. V. Lohmann, F. Körner, J.O. Koch, U. Herian, L. Theilmann, and R. Bartenschlager Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line Science 285 1999 110 113
5. R. Bartenschlager, M. Frese, and T. Pietschmann Novel insights into hepatitis C virus replication and persistence Adv Virus Res 63 2004 71 180
6. V. Lohmann, S. Hoffmann, U. Herian, F. Penin, and R. Bartenschlager Viral and cellular determinants of hepatitis C virus RNA replication in cell culture J Virol 77 2003 3007 3019
7. K.J. Blight, A.A. Kolykhalov, and C.M. Rice Efficient initiation of HCV RNA replication in cell culture Science 290 2000 1972 1974
8. M.J. Evans, C.M. Rice, and S.P. Goff Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication Proc Natl Acad Sci USA 101 2004 13038 13043
9. P. Neddermann, M. Quintavalle, C. Di Pietro, A. Clementi, M. Cerretani, and S. Altamura Reduction of hepatitis C virus NS5A hyperphosphorylation by selective inhibition of cellular kinases activates viral RNA replication in cell culture J Virol 78 2004 13306 13314
10. Appel N, Pietschmann T, Bartenschlager R. Mutation analysis of hepatitis C virus nonstructural protein 5A: potential role of differential phosphorylation for RNA replication and identification of a genetically flexible domain. J Virol, in press.
11. K.J. Blight, J.A. McKeating, and C.M. Rice Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication J Virol 76 2002 13001 13014
12. E.M. Murray, J.A. Grobler, E.J. Markel, M.F. Pagnoni, G. Paonessa, and A.J. Simon Persistent replication of hepatitis C virus replicons expressing the beta-lactamase reporter in subpopulations of highly permissive Huh7 cells J Virol 77 2003 2928 2935
13. R. Bartenschlager Hepatitis C virus replicons: potential role for drug development Nat Rev Drug Discov 1 2002 911 916
14. T. Date, T. Kato, M. Miyamoto, Z. Zhao, K. Yasui, and M. Mizokami Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells J Biol Chem 279 2004 22371 22376
15. S. Ali, C. Pellerin, D. Lamarre, and G. Kukolj Hepatitis C virus subgenomic replicons in the human embryonic kidney 293 cell line J Virol 78 2004 491 501
16. T. Kato, T. Date, M. Miyamoto, Z. Zhao, M. Mizokami, and T. Wakita Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon J Virol 79 2005 592 596
17. Q. Zhu, J.T. Guo, and C. Seeger Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells J Virol 77 2003 9204 9210
18. T. Pietschmann, V. Lohmann, A. Kaul, N. Krieger, G. Rinck, and G. Rutter Persistent and transient replication of full-length hepatitis C virus genomes in cell culture J Virol 76 2002 4008 4021
19. M. Ikeda, M. Yi, K. Li, and S.M. Lemon Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells J Virol 76 2002 2997 3006
20. K.J. Blight, J.A. McKeating, J. Marcotrigiano, and C.M. Rice Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture J Virol 77 2003 3181 3190
21. T. Kato, T. Date, M. Miyamoto, A. Furusaka, K. Tokushige, and M. Mizokami Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon Gastroenterology 125 2003 1808 1817
22. J. Bukh, T. Pietschmann, V. Lohmann, N. Krieger, K. Faulk, and R.E. Engle Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees Proc Natl Acad Sci USA 99 2002 14416 14421
23. N. Nakajima, M. Hijikata, H. Yoshikura, and Y.K. Shimizu Characterization of long-term cultures of hepatitis C virus J Virol 70 1996 3325 3329
24. M. Ikeda, K. Sugiyama, T. Mizutani, T. Tanaka, K. Tanaka, and H. Sekihara Human hepatocyte clonal cell lines that support persistent replication of hepatitis C virus Virus Res 56 1998 157 167
25. T. Pietschmann, V. Lohmann, G. Rutter, K. Kurpanek, and R. Bartenschlager Characterization of cell lines carrying self-replicating hepatitis C virus RNAs J Virol 75 2001 1252 1264
26. R.E. Lanford, B. Guerra, H. Lee, D.R. Averett, B. Pfeiffer, and D. Chavez Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons J Virol 77 2003 1092 1104
27. J.T. Guo, Q. Zhu, and C. Seeger Cytopathic and noncytopathic interferon responses in cells expressing hepatitis C virus subgenomic replicons J Virol 77 2003 10769 10779
28. N. Enomoto, I. Sakuma, Y. Asahina, M. Kurosaki, T. Murakami, and C. Yamamoto Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region J Clin Invest 96 1995 224 230
29. N. Enomoto, I. Sakuma, Y. Asahina, M. Kurosaki, T. Murakami, and C. Yamamoto Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection N Engl J Med 334 1996 77 81
30. M. Frese, T. Pietschmann, D. Moradpour, O. Haller, and R. Bartenschlager Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway J Gen Virol 82 2001 723 733
31. J.T. Guo, V.V. Bichko, and C. Seeger Effect of alpha interferon on the hepatitis C virus replicon J Virol 75 2001 8516 8523
32. C. Sarrazin, E. Herrmann, K. Bruch, and S. Zeuzem Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses J Virol 76 2002 11079 11090
33. A.U. Neumann, N.P. Lam, H. Dahari, D.R. Gretch, T.E. Wiley, and T.J. Layden Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy Science 282 1998 103 107
34. R. De Francesco, and C.M. Rice New therapies on the horizon for hepatitis C: are we close? Clin Liver Dis 7 2003 211 242
35. A. Pause, G. Kukolj, M. Bailey, M. Brault, F. Do, and T. Halmos An NS3 serine protease inhibitor abrogates replication of subgenomic hepatitis C virus RNA J Biol Chem 278 2003 20374 20380
36. M. Llinas-Brunet, M.D. Bailey, E. Ghiro, V. Gorys, T. Halmos, and M. Poirier A systematic approach to the optimization of substrate-based inhibitors of the hepatitis C virus NS3 protease: discovery of potent and specific tripeptide inhibitors J Med Chem 47 2004 6584 6594
37. D. Lamarre, P.C. Anderson, M. Bailey, P. Beaulieu, G. Bolger, and P. Bonneau An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus Nature 426 2003 186 189
38. H. Hinrichsen, Y. Benhamou, H. Wedemeyer, M. Reiser, R.E. Sentjens, and J.L. Calleja Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients Gastroenterology 127 2004 1347 1355
39. S.E. VanCompernolle, A.V. Wiznycia, J.R. Rush, M. Dhanasekaran, P.W. Baures, and S.C. Todd Small molecule inhibition of hepatitis C virus E2 binding to CD81 Virology 314 2003 371 380
40. A. Mehta, B. Conyers, D.L. Tyrrell, K.A. Walters, G.A. Tipples, and R.A. Dwek Structure-activity relationship of a new class of anti-hepatitis B virus agents Antimicrob Agents Chemother 46 2002 4004 4008
41. L. Lu, T.J. Pilot-Matias, K.D. Stewart, J.T. Randolph, R. Pithawalla, and W. He Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitro Antimicrob Agents Chemother 48 2004 2260 2266
42. T.T. Nguyen, A.T. Gates, L.L. Gutshall, V.K. Johnston, B. Gu, and K.J. Duffy Resistance profile of a hepatitis C virus RNA-dependent RNA polymerase benzothiadiazine inhibitor Antimicrob Agents Chemother 47 2003 3525 3530
43. C. Trozzi, L. Bartholomew, A. Ceccacci, G. Biasiol, L. Pacini, and S. Altamura In vitro selection and characterization of hepatitis C virus serine protease variants resistant to an active-site peptide inhibitor J Virol 77 2003 3669 3679
44. G. Migliaccio, J.E. Tomassini, S.S. Carroll, L. Tomei, S. Altamura, and B. Bhat Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro J Biol Chem 278 2003 49164 49170
45. R. Sumpter Jr, C. Wang, E. Foy, Y.M. Loo, and M. Gale Jr Viral evolution and interferon resistance of hepatitis C virus RNA replication in a cell culture model J Virol 78 2004 11591 11604
46. K. Namba, K. Naka, H. Dansako, A. Nozaki, M. Ikeda, and Y. Shiratori Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype Biochem Biophys Res Commun 323 2004 299 309
47. J.Y. Lau, R.C. Tam, T.J. Liang, and Z. Hong Mechanism of action of ribavirin in the combination treatment of chronic HCV infection Hepatology 35 2002 1002 1009
48. S. Crotty, D. Maag, J.J. Arnold, W. Zhong, J.Y. Lau, and Z. Hong The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen Nat Med 6 2000 1375 1379
49. K.C. Young, K.L. Lindsay, K.J. Lee, W.C. Liu, J.W. He, and S.L. Milstein Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy Hepatology 38 2003 869 878
50. N.M. Dixit, J.E. Layden-Almer, T.J. Layden, and A.S. Perelson Modelling how ribavirin improves interferon response rates in hepatitis C virus infection Nature 432 2004 922 924
51. C. Logvinoff, M.E. Major, D. Oldach, S. Heyward, A. Talal, and P. Balfe Neutralizing antibody response during acute and chronic hepatitis C virus infection Proc Natl Acad Sci USA 101 2004 10149 10154
52. R. Burioni, N. Mancini, S. Carletti, M. Perotti, A. Grieco, and F. Canducci Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection Virology 327 2004 242 248
53. B. Bartosch, J. Bukh, J.C. Meunier, C. Granier, R.E. Engle, and W.C. Blackwelder In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes Proc Natl Acad Sci USA 100 2003 14199 14204
54. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon ACM, Ikeda M, et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 2005;102:2992-2997.